Denmark vs Malaysia: Hepatitis B surface antigen (HBsAg) prevalence
Denmark
0.1%
in 2024
Malaysia
0.1%
in 2024
Denmark rank
101st
Malaysia rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Denmark
- Malaysia
How they compare
Denmark currently reports 0.1% against 0.1% in Malaysia, a difference of 0.0%.
Across all 10 years both countries report, Malaysia has been ahead every year.
Denmark ranks 101st and Malaysia ranks 101st of 194 countries.
Malaysia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.2% | 0.0% | Malaysia |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Denmark or Malaysia?
- Denmark, at 0.1% against 0.1% in Malaysia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Denmark and Malaysia?
- 0.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Malaysia?
- 10 years are reported by both, from 2015 to 2024.
- How do Denmark and Malaysia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Denmark ranks 101st and Malaysia ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.